Share

DKBmed Radio

DKBmed Radio podcast chanel

DKBmed Radio provides health care clinicians with expert insight and analysis in a wide variety of disease states and specialty areas. Earn continuing medical education (CME) credit by listening to the episode and visiti

Latest Episode6/21/2022

Race, Ethnicity, and Cystic Fibrosis

Race and ethnicity. How do they affect a patient’s ability to receive a timely and accurate cystic fibrosis diagnosis? How do the social determinants of health limit access to appropriate CF treatment and produce poorer outcomes?That’s what we’re here to talk about today with Dr. Jennifer Taylor-Cousar from National Jewish Health and Children’s Hospital Colorado in thiseCysticFibrosis Reviewpodcast.Take ourpost-testto claim CME credits.Read this podcast's companion newsletter here.

Race, Ethnicity, and Cystic Fibrosis

Race and ethnicity. How do they affect a patient’s ability to receive a timely and accurate cystic fibrosis diagnosis? How do the social determinants of health limit access to appropriate CF treatment and produce poorer outcomes?That’s what we’re here to talk about today with Dr. Jennifer Taylor-Cousar from National Jewish Health and Children’s Hospital Colorado in thiseCysticFibrosis Reviewpodcast.Take ourpost-testto claim CME credits.Read this podcast's companion newsletter here.

6/1/2022 - State of COVID-19

Dr. Paul Auwaerter discusses the current state of COVID-19 including treatment updates. Topics: *Information on new Omicron subvariants *CDC advisory about rebound COVID-19 *Latest treatment information *Post-COVID conditionsPost-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/6-1-22-episode/evalAccess our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialtyPresenting faculty:Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine

5/11/2022 - COVID-19 Omicron Impact on Vaccines

Dr. Paul Auwaerter discusses the effect of the Omicron variant, including its subvariants, on COVID-19 vaccines. Topics: *Impact of Omicron on mRNA boosters *Analyzing Omicron and BA.2 subvariants *Interpreting CDC vaccine data *Protection level of one-way maskingPost-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/5-11-22-episode/evalAccess our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialtyPresenting faculty:Paul Auwaerter, MD, MBA, FIDSA, Clinical Director, Division of Infectious Diseases, Sherrilyn and Ken Fisher Professor of Medicine, Fisher Center for Environmental Infectious Diseases, Johns Hopkins University School of Medicine

4/26/2022 - COVID-19 Prevention Update

Paul G. Auwaerter, MD, MBA, FIDSA and Michael Angarone, DO, FIDSA discuss the latest guidelines for prevention of COVID-19. Topics: *Updates on the BA.2 subvariant *Who should get a second booster? And when? *What conditions and factors place people at higher risk for severe COVID? *Pre-exposure prophylaxis for COVID-19 prevention *Mitigating risk of disease progressionPost-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-26-22-episode/evalAccess our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialtyPresenting faculty:Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Sherrilyn and Ken Fisher Professor of Medicine at Johns Hopkins University School of MedicineMichael Angarone, DO, FIDSA, Associate Professor, Division of Infectious Diseases, Departments of Medicine and Medical Education at Northwestern University Feinberg School of Medicine

4/6/2022 - New COVID-19 Treatment Guidelines

Paul G. Auwaerter, MD, MBA, FIDSA and David Klimpl, MD discuss current treatments for patients hospitalized with COVID-19. Topics: *New data on efficacy of available therapies *Immunomodulators for critical care patients *Updated NIH recommendationsPost-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-6-22-episode/evalAccess our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialtyPresenting faculty:Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Sherrilyn and Ken Fisher Professor of Medicine at Johns Hopkins University School of MedicineDavid Klimpl, MD, Assistant Professor at University of Colorado Denver – Anschutz Medical Campus

Clinical Uses of LA Injectable ART

Long-acting injectable antiretroviral therapy is expected to improve adherence, reduce patient burden, and lower community viral load. But for which patients is it suitable? Can it be used as pre-exposure prophylaxis? How does the promise of long-acting ART actually mean in practice?</p><p>Join us for this <em>e</em>HIV Review podcast, as Dr. Tanyaporn Wansom, Senior Infectious Diseases Consultant at Chayun Consulting in Bangkok Thailand, takes us to the clinic to answer some of these key questionsTake ourpost-testto claim CME credits.To read a companion newsletterclick here.

4/13/2022 - COVID-19 Vaccine Boosters & BA.2

Dr. Paul Auwaerter discusses new vaccine boosters, global impact of the pandemic, and the BA.2 Subvariant. Topics: *New boosters in the future? *Challenges of additional boosters *Cardiac concerns with COVID-19 vaccines? *Collateral effects from the pandemic *Latest news on BA.2 SubvariantPost-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-13-22-episode/evalAccess our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialtyPresenting faculty:Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine

VIEW ALL